96710 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#2FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS
#3PEPTIDES BINDING TO HYPOXIA INDUCIBLE FACTORS AND THEIR USE
#4FORMULATION OF MODIFIED INTERLEUKIN-7 FUSION PROTEIN
#5TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME
#6SELECTIVE SMALL MOLECULE AGONISTS AND PARTIAL AGONISTS OF TRK RECEPTORS
#7PURIFICATION OF SPECIFIC TRIPEPTIDE BY ACIDIFICATION
#8TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#9METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#10Solution phase routes for WNT hexapeptides
#11FORMULATION OF MODIFIED INTERLEUKIN-7 FUSION PROTEIN
#12NOVEL DOPAMINE PRECURSORS
#13SMALL MOLECULE INHIBITORS OF SARS-CoV-2 VIRAL REPLICATION AND USES THEREOF
#14Peptide macrocycles against
#15Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers
#16DMSO-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND USE THEREOF
#17CSF1R-BASED CHIMERIC PROTEINS
#18Transfection complexes and methods of using the same
#19PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY
#20METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#21FAP-activated proteasome inhibitors for treating solid tumors
#22DOPAMINE PRECURSORS
#23Toll-like receptor 2 ligands and methods of making and using thereof
#24Solution phase routes for Wnt hexapeptides
#25BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES
#26Compositions comprising cyclic peptides derived from an A-beta peptide
#27PEPTIDE COMPOSITIONS AND RELATED METHODS
#28PEPTIDE COMPOSITIONS AND RELATED METHODS
#29Proteasome inhibitors
#30FAP-activated proteasome inhibitors for treating solid tumors
#31PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#32Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#33Pro-pigmenting peptides
#34Peptide inhibitors of tight junction permeability
#35Preparation and use of molecular site targeted and activated kinase inhibitor
#36CSF1R-based chimeric proteins
#37Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#38Interferon Analogs
#39CSF1R-CD40L chimeric proteins
#40Peptide macrocycles against
#41Toll-like receptor 2 ligands and methods of making and using thereof
#42PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#43CSF1R-based chimeric proteins
#44Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#45Pro-pigmenting peptides
#46PAR3 mimetic peptides and uses thereof
#47PAR2 mimetic peptides and uses thereof
#48Radiolabeled drug
#49METHODS OF TREATING DEPRESSION AND OTHER RELATED DISEASES
#50FAP-activated proteasome inhibitors for treating solid tumors
#51Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
#52Difluoroketamide derivatives as HtrA1 inhibitors
#53Peptide macrocycles against Acinetobacter baumannii
#54Skin treatment devices and methods with pre-stressed configurations
#55Transfection complexes and methods of using the same
#56Formulation of modified interleukin-7 fusion protein
#57Interferon analogs
#58NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
#59Selective cysteine protease inhibitors and uses thereof
#60Cahuitamycins and methods of making and using the same
#61Prodrugs of peptide epoxy ketone protease inhibitors
#62Inhibition of gliadin peptides
#63NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#64Methods of treating depression and other related diseases
#65Solution phase method for preparing etelcalcetide
#66Indoline compounds as granzyme B inhibitors
#67Toll-like receptor 2 ligands and methods of making and using thereof
#68BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES
#69Compounds for enzyme inhibition
#70Peptide macrocycles against acinetobacter baumannii
#71Methods and compositions for stimulating collagen synthesis in skin cells
#72HCV PROTEASE INHIBITORS AND USES THEREOF
#73INHIBITION OF GLIADIN PEPTIDES
#74Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#75Biologically active C-terminal arginine-containing peptides
#76Pro-pigmenting peptides
#77Method of inhibiting activity of cell surface fibroblast activation protein alpha
#78Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same
#79CONTEMPORANEOUS, HETEROGENEOUSLY-ORIENTED, MULTI-TARGETED THERAPEUTIC MODIFICATION AND/OR MODULATION OF DISEASE BY ADMINISTRATION OF SULFUR-CONTAINING, AMINO ACID-SPECIFIC SMALL MOLECULES
#80FAP-activated proteasome inhibitors for treating solid tumors
#81Antibody that specifically binds partially processed or unprocessed neurotoxin polypeptides
#82Interferon Analogs
#83Prodrugs of peptide epoxy ketone protease inhibitors
#84HCV protease inhibitors and uses thereof
#85NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#86Skin treatment devices and methods with pre-stressed configurations
#87PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#88Compositions and methods of treatment of cancers
#89Process for the manufacture of degarelix and its intermediates
#90Indoline compounds as granzyme B inhibitors
#91Method of Forming Fragment Ligated Inhibitors
#92Methods of treating depression and other related diseases
#93Hepatitis C virus inhibitors
#94p53 activating peptides
#95Fragment ligated inhibitors selective for the polo box domain of PLK1
#96Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#97Hepatitis C virus inhibitors
#98Pro-pigmenting peptides
#99INHIBITION OF GLIADIN PEPTIDES
#100Derivatives of pyridinone as inhibitors for tissue transglutaminase
#101Peptides and use thereof
#102HCV protease inhibitors and uses thereof
#103Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same
#104Modulators of protease activated receptors
#105Niacin-peptide having skin whitening activity and use for same
#106Selective caspase inhibitors and uses thereof
#107USE OF PEPTIDE EPOXYKETONES FOR METASTASIS SUPPRESSION
#108Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
#109IAP BIR domain binding compounds
#110Compounds, compositions and methods for the treatment of diseases through inhibiting TGF-β activity
#111Macrocyclic hepatitis C serine protease inhibitors
#112FAP-activated proteasome inhibitors for treating solid tumors
#113Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#114Prion protein ligands and methods of use
#115Macrocyclic broad spectrum antibiotics
#116Prodrugs of peptide epoxy ketone protease inhibitors
#117Prodrugs of peptide epoxy ketone protease inhibitors
#118sGCalphal inhibiting compositions
#119Compounds for enzyme inhibition
#120Compounds for enzyme inhibition
#121Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
#122Selective cysteine protease inhibitors and uses thereof
#123Compounds for enzyme inhibition
#124Neuroprotective and neurorestorative methods and compositions
#125Methods and compositions related to internalizing RGD peptides
#126HCV protease inhibitors and uses thereof
#127Methods of treating depression and other related diseases
#128Methods of treating depression and other related diseases
#129Methods of treating depression and other related diseases
#130Process for the manufacture of Degarelix and its intermediates
#131TREATMENT OF INFLAMMATORY BOWEL DISEASES USING A TRIPEPTIDE
#132Small peptides and methods for blocking IGE mediated activation of an immune cell
#133Skin treatment devices and methods with pre-stressed configurations
#134Modulations of protease activated receptors
#135Derivatives of glyco-CF-serine and glyco-CF-threonine
#136Aziridine mediated native chemical ligation
#137COMPOUNDS FOR ENZYME INHIBITION
#138IAP BIR domain binding compounds
#139Interferon analogs
#140Use of peptide epoxyketones for metastasis suppression
#141HCV protease inhibitors and uses thereof
#142Methods of treating depression and other related diseases
#143Methods of treating depression and other related diseases
#144Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#145Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
#146Phalloidin derivatives and methods for their synthesis
#147Peptide for augmenting and expression of BDNF and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including Alzheimer's disease or Parkinson's disease, comprising the same
#148Fragment ligated inhibitors selective for the polo box domain of PLK1
#149HCV protease inhibitors and uses thereof
#150Macrocyclic hepatitis C serine protease inhibitors
#151Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
#152Mass spectrometric methods and products
#153Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
#154Treatment devices and methods with extending elements
#155Skin treatment devices and methods with pre-stressed configurations
#156Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#157AGENT FOR PREVENTING ARTERIOSCLEROSIS, AGENT FOR SUPPRESSING VASCULAR INTIMAL THICKENING AND AGENT FOR IMPROVING VASCULAR ENDOTHELIAL FUNCTION
#158Neuroprotective and neurorestorative method and compositions
#159TUMOR NECROSIS FACTOR INHIBITING PEPTIDES AND USES THEREOF
#160Means and methods for manufacturing highly pure neurotoxin
#161Cysteine-free efficient Technetium (Tc) or Rhenium (Re) chelating peptide tags and their use
#162Inhibiting tumor cell invasion, metastasis and angiogenesis
#163Inhibition of gliadin peptides
#164NOVEL ANTI-AGING PEPTIDES AND COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING SAME
#165Peptides having an ACE inhibiting effect
#166Small molecule inhibitors of MUC1 and methods of identifying the same
#167Oligomeric biosurfactants in dermatocosmetic compositions
#168Peptide-containing culture medium for culturing animal cell
#169MULTI-COMPONENT ANTIOXIDANT COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE FOR REDUCING OR PREVENTING OXIDATIVE STRESS
#170Biologically active C-terminal arginine-containing peptides
#171Inhibitors of serine proteases
#172Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
#173Gene regulator
#174Flexibly labeling peptides
#175Casein hydrolyzate, process for producing the same and use thereof
#176Inhibitors of mammalian tight junction opening
#177Selective caspase inhibitors and uses thereof
#178Mass spectrometric methods and products
#179Molecular Interactions in Neurons
#180CRIPTO BLOCKING MOLECULES AND THERAPEUTIC USES THEREOF
#181Substrate for assaying β-glucan and/or endotoxin and assay method
#182Treatment of burns
#183Nucleic acid binding compounds and methods of use
#184Methods and intermediates for chemical synthesis of polypeptides and proteins
#185DECHALCOGENATIVE METHODS FOR THE PREPARATION OF ALLYLIC SULFIDES
#186IAP BIR DOMAIN BINDING COMPOUNDS
#187HCV NS3 PROTEASE INHIBITORS
#188Targeted delivery to legumain-expressing cells
#189Inhibitors of Hepatitis C NS3 Protease
#190Hepatitis C virus inhibitors
#191HCV protease inhibitors and uses thereof
#192HCV protease inhibitors and uses thereof
#193HCV protease inhibitors and uses thereof
#194Peptides directed for diagnosis and treatment of amyloid-associated diseases
#195PROCESS FOR DETECTING ENZYME ACTIVITY IN AN IMMUNOASSAY
#196Mass spectrometric methods and products
#197Peptides having an ace inhibiting effect
#198Peptides Having an Ace Inhibiting Effect
#199AGENT FOR PREVENTING ARTERIOSCLEROSIS, AGENT FOR SUPPRESSING VASCULAR INTIMAL THICKENING AND AGENT FOR IMPROVING VASCULAR ENDOTHELIAL FUNCTION
#200HCV PROTEASE INHIBITORS
#201Selective substrates for matrix metalloproteinases
#202Methods and compositions related to internalizing RGD peptides
#203Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#204Treatment methods using peptides related to amyloid precursor protein
#205Methods and uses for protein breakdown products
#206Compounds for enzyme inhibition
#207NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY
#208Inhibiting tumor cell invasion, metastasis and angiogenesis
#209Peptide ligands
#210Methods for the treatment or prevention of scars and/or keloids
#211Peptide inhibiting angiotensin converting enzyme
#212Process for making macrocyclic oximyl hepatitis C protease inhibitors
#213Methionine aminopeptidase-2 inhibitors and methods of use thereof
#214Biologically active C-terminal arginine-containing peptides
#215Novel Nutraceutical Compositions
#216Immunoregulatory compositions
#217Prion protein ligands and methods of use
#218Peptide compositions
#219Small peptides and methods for inhibiting the infiltration of eosinophils into airways
#220Small Peptides And Methods For Inhibiting The Migration Of T-Cells
#221Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
#222Small peptides and methods for inhibiting mucus release into airways
#223Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
#224Small Peptides And Methods For Treatment Of Chronic Obstruction Pulmonary Disease
#225Small Peptides And Methods For Treatment Of Arthritis
#226IAP BIR domain binding compounds
#227Small Peptides And Methods For Stabilizing The Cell Membrane Of An Immune Cell
#228Gene regulator
#229Treatment of burns
#230Treatment methods using polypeptides related to amyloid precursor protein
#231Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#232Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
#233Flexibly labeling peptides
#234IMMUNOREGULATORY COMPOSITIONS
#235IAP BIR domain binding compounds
#236Casein hydrolyzate, process for producing the same and use thereof
#237Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
#238Tripeptide prodrug compounds
#239Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
#240Inhibitors of serine proteases
#241Pyrrolidine melanocortin-specific compounds
#242Biogically non-degradable peptides, angiostensin converting enzyme inhibitor, drug and functional food
#243Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#244Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#245Compounds for enzyme inhibition
#246Hepatitis C virus inhibitors
#247Anti-inflammatory peptides
#248Treatment of ischemic events
#249Peptides and mimetics for reducing symptoms of toxic shock syndrome and septic shock
#250Methionine aminopeptidase-2 inhibitors and methods of use thereof
#251Hepatitis C inhibitor peptide analogs
#252Peptides directed for diagnosis and treatment of amyloid-associated disease
#253Therapeutic agents and methods of use thereof for the treatment of melanoma
#254Molecular interactions in neurons
#255Targeted delivery to legumain-expressing cells
#256Synthetic glyco-lipo-peptides as vaccines
#257Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#258Methods for identifying RNA binding compounds
#259Di-, tri-, and tetra-peptides having antiangiogenic activity
#260Gene regulatory peptides
#261Selective substrates for matrix metalloproteinases
#262Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#263Peptide compositions for treatment of sexual dysfunction
#264Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
#265Annexin derivatives with endogenous chelation sites
#266Methionine aminopeptidase-2 inhibitors and methods of use thereof
#267Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#268Methods and uses for protein breakdown products
#269Peptide having angiotensin converting enzyme inhibitory effect